New hope for thyroid eye disease: gentler treatment challenge to steroids
NCT ID NCT04936854
Summary
This study is testing if a drug called sirolimus is a better and safer option than standard steroid treatment for people with active thyroid eye disease. It will involve 60 adults with moderate-to-severe symptoms that started within the last 9 months. Researchers will compare how well each treatment reduces eye inflammation and swelling, and track which causes fewer side effects like weight gain or high blood pressure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID ASSOCIATED OPHTHALMOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Ophthalmology Haukeland University Hospital
RECRUITINGBergen, Hordaland, 5021, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.